BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The BioCalendar
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260226T110000
DTEND;TZID=America/Los_Angeles:20260226T120000
DTSTAMP:20260422T123746
CREATED:20260211T185945Z
LAST-MODIFIED:20260211T185945Z
UID:9887-1772103600-1772107200@thebiocalendar.com
SUMMARY:Chemoenzymatic Ligation: A New Frontier in siRNA Manufacturing
DESCRIPTION:The current oligo manufacturing paradigm relies on solid-phase synthesis\, a process heavily reliant on organic solvents/raw materials. However\, siRNA manufacturers—both biotechs and CDMOs—are in the process of starting a slow but important manufacturing transition away from solid phase synthesis toward enzymatic production\, starting with enzymatic ligation for siRNA products. This will be a closer look at the current state of affairs for enzymatic ligation—where advancements have been made\, as well as where the pain points are in building this into current processes.
URL:https://thebiocalendar.com/event/chemoenzymatic-ligation-a-new-frontier-in-sirna-manufacturing/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/26_02-ARNA-WebPopUp-460x180-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260226T100000
DTEND;TZID=America/Los_Angeles:20260226T150000
DTSTAMP:20260422T123746
CREATED:20251230T163108Z
LAST-MODIFIED:20251230T163108Z
UID:9685-1772100000-1772118000@thebiocalendar.com
SUMMARY:Bio-Expo Live: Bioprocess Quality\, Data\, & Analytical Solutions
DESCRIPTION:Bioprocess Online’s Bio-Expo Live is back with its series of live virtual events designed to empower biopharma professionals. Through these sessions\, attendees will have the chance to explore the newest equipment and solutions offered by our presenters\, aimed at addressing the current challenges within the drug development process. This interactive online platform ensures convenience and accessibility\, fostering an environment of learning and innovation for all participants. \nThe attendees of the Data\, Quality\, & Analytical session will have the chance to explore the latest equipment and solutions offered by our presenting suppliers essential to biopharmaceutical development and manufacturing. \nWhat can you expect? Short\, digital presentations with live interaction. You will have the opportunity to ask questions to better understand if they can meet your needs – all from the convenience of your computer! \nPlease note that this event is for biopharma companies or contract manufacturers seeking available quality\, data\, and/or analytical products/solutions to help them overcome their manufacturing challenges.
URL:https://thebiocalendar.com/event/bio-expo-live-bioprocess-quality-data-analytical-solutions-2/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2025/12/2026_bel_reg_1920x250_bioprocess_quality_data_and_analytical_solutions1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260226
DTEND;VALUE=DATE:20260227
DTSTAMP:20260422T123746
CREATED:20260128T112856Z
LAST-MODIFIED:20260128T112856Z
UID:9828-1772064000-1772150399@thebiocalendar.com
SUMMARY:The Leadership Meeting
DESCRIPTION:The Demy-Colton Executive Clinics\, part of the Global Biotech CEO Summit family of conferences\, are designed to advance the capabilities of current and future life science executives. These intensive\, one-day sessions deliver actionable insights into critical leadership\, operational\, and governance challenges facing the sector. \n\nTHE LEADERSHIP MEETING: Optimize leadership strategies to govern with agility\, navigate uncertainty\, and build a resilient organization for long-term success. \n\n\n\nAttendees will engage with expert facilitators and industry leaders to explore strategies for effective decision-making\, board governance\, deal-making\, and fund raising. The Clinics are designed to foster meaningful dialogue and ensure a focused\, results-oriented experience.
URL:https://thebiocalendar.com/event/the-leadership-meeting/
LOCATION:New York\, New York\, NY\, United States
CATEGORIES:Symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260225T120000
DTEND;TZID=America/Los_Angeles:20260225T130000
DTSTAMP:20260422T123746
CREATED:20260127T144047Z
LAST-MODIFIED:20260127T144047Z
UID:9816-1772020800-1772024400@thebiocalendar.com
SUMMARY:Beyond Standard Approaches: Integrated Thinking for Complex FIH Programs
DESCRIPTION:While platform approaches can effectively expedite standard programs\, innovators often confront molecules with unique challenges and unanticipated technical hurdles. These programs require a team that has not only the technical depth but also the experience to anticipate the distinct risks and opportunities embedded in each molecule’s story. Success depends on seeing beyond the immediate scope of work and viewing the molecule’s life holistically linking early development decisions to later-stage outcomes ensures that scientific insight transcends functional boundaries. \nThis webinar covers real-world examples where deep expertise\, integrated thinking\, and cross-functional collaboration came together to transform complex challenges into innovation opportunities. Rather than focusing on platforms or capabilities\, the session highlights how integrated\, systems-level thinking streamlines decision-making and reshapes development trajectories for even the most unconventional First-in-Human programs.
URL:https://thebiocalendar.com/event/beyond-standard-approaches-integrated-thinking-for-complex-fih-programs/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/02-25-26-IQVIA-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260225T110000
DTEND;TZID=America/Los_Angeles:20260225T120000
DTSTAMP:20260422T123746
CREATED:20260127T143205Z
LAST-MODIFIED:20260127T143205Z
UID:9812-1772017200-1772020800@thebiocalendar.com
SUMMARY:Qualified eSignature in Electronic Consent Systems - A Primer for Clinical Trial Professionals
DESCRIPTION:Electronic consent (eConsent) systems have proven to add value to patients\, sponsors\, and sites. However\, varying regulations across regions and countries can impact implementation of eConsent solutions and dilute the benefits. How can clinical trial professionals adapt a global approach to eConsent rollouts that accounts for these differences? \nJoin IQVIA Technologies for an informative webinar on electronic signature (eSignature) technology for eConsent. We’ll delve into global regulatory scenarios and options for meeting eSignature requirements in each scenario\, including the benefits and limitations of: \n– Print to sign\n– Simple or Electronic Signature (SeS)\n– Advanced Electronic Signature (AeS)\n– Qualified Electronic Signature (QeS) \nLearn what to look for in eConsent solutions to ensure you’re prepared for every trial.
URL:https://thebiocalendar.com/event/qualified-esignature-in-electronic-consent-systems-a-primer-for-clinical-trial-professionals/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/02-25-26-IQVIA-Custom-Email-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260225T100000
DTEND;TZID=America/Los_Angeles:20260225T150000
DTSTAMP:20260422T123746
CREATED:20251230T162823Z
LAST-MODIFIED:20251230T163213Z
UID:9681-1772013600-1772031600@thebiocalendar.com
SUMMARY:Bio-Expo Live: Downstream Bioprocessing
DESCRIPTION:Bioprocess Online’s Bio-Expo Live is back with its series of live virtual events designed to empower biopharma professionals. Through these sessions\, attendees will have the chance to explore the newest equipment and solutions offered by our presenters\, aimed at addressing the current challenges within the drug development process. This interactive online platform ensures convenience and accessibility\, fostering an environment of learning and innovation for all participants. \nThe attendees of the Downstream Manufacturing session will have the chance to explore the newest equipment and solutions offered by our presenting suppliers essential to Therapeutic areas from ADCs to Vaccines. \nWhat can you expect? Short\, digital presentations with live interaction. You will have the opportunity to ask questions to better understand if they can meet your needs – all from the convenience of your computer! \nPlease note that this event is for biopharma companies or contract manufacturers seeking available products/solutions to help them overcome downstream manufacturing challenges.
URL:https://thebiocalendar.com/event/bio-expo-live-downstream-bioprocessing-2/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2025/12/2026_bel_reg_1920x250_downstream_bioprocessing1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260224T110000
DTEND;TZID=America/Los_Angeles:20260224T120000
DTSTAMP:20260422T123746
CREATED:20260129T143310Z
LAST-MODIFIED:20260129T143310Z
UID:9830-1771930800-1771934400@thebiocalendar.com
SUMMARY:Closer to Home: Rethinking API Manufacturing
DESCRIPTION:This is your chance to learn strategies on how to mitigate geopolitical risks and navigate the technical complexities of reshoring your supply chain. This session provides a strategic roadmap for facility design\, advanced manufacturing technologies\, and navigating new FDA programs like FDA PreCheck and leveraging policy incentives to build a sustainable\, cost-efficient manufacturing footprint. Join us and experts from Eli Lilly\, USP\, and the API Innovation Center.
URL:https://thebiocalendar.com/event/closer-to-home-rethinking-api-manufacturing/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/26_02-POL-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260224T100000
DTEND;TZID=America/Los_Angeles:20260224T150000
DTSTAMP:20260422T123746
CREATED:20251230T162507Z
LAST-MODIFIED:20251230T162507Z
UID:9677-1771927200-1771945200@thebiocalendar.com
SUMMARY:Bio-Expo Live: Upstream Bioprocessing
DESCRIPTION:Bioprocess Online’s Bio-Expo Live is back with its series of live virtual events designed to empower biopharma professionals. Through these sessions\, attendees will have the chance to explore the newest equipment and solutions offered by our presenters\, aimed at addressing the current challenges within the drug development process. This interactive online platform ensures convenience and accessibility\, fostering an environment of learning and innovation for all participants. \nThe attendees of the Upstream Manufacturing session will have the chance to explore the newest equipment and solutions offered by our presenting suppliers essential to therapeutic areas from ADCs to vaccines. \nWhat can you expect? Short\, digital presentations with live interaction. You will have the opportunity to ask questions to better understand if they can meet your needs – all from the convenience of your computer! \nPlease note that this event is for biopharma companies or contract manufacturers seeking available products/solutions to help them overcome upstream manufacturing challenges.
URL:https://thebiocalendar.com/event/bio-expo-live-upstream-bioprocessing-3/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2025/12/2026_bel_reg_1920x250_upstream_bioprocessing1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260224
DTEND;VALUE=DATE:20260227
DTSTAMP:20260422T123746
CREATED:20260105T162210Z
LAST-MODIFIED:20260105T162211Z
UID:9707-1771891200-1772150399@thebiocalendar.com
SUMMARY:Biocom California's Global Partnering & Investor Conference
DESCRIPTION:Biocom California’s 16th Annual Global Life Science Partnering & Investor Conference is an exclusive global partnering and networking forum that brings together over 500 investors and senior executives\, including CEOs and heads of business development\, licensing\, M&A\, and research and development from leading pharmaceutical\, biotech\, and research organizations from over 20 countries. Join us in San Diego where industry leaders will debate current trends\, companies will showcase their latest technologies and all attendees will have the opportunity to schedule partnering meetings with leading dealmakers.
URL:https://thebiocalendar.com/event/biocom-californias-global-partnering-investor-conference/
LOCATION:La Jolla
CATEGORIES:Investor,Partnering
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260223T110000
DTEND;TZID=America/Los_Angeles:20260223T120000
DTSTAMP:20260422T123746
CREATED:20260127T203804Z
LAST-MODIFIED:20260127T203804Z
UID:9810-1771844400-1771848000@thebiocalendar.com
SUMMARY:From Concept to Market: Scaling and Manufacturing Semi-Solid Topical Drugs (Free Webinar)
DESCRIPTION:Bringing a semi-solid topical drug from the lab to commercial manufacturing is anything but straightforward. Join this expert-led webinar to explore the critical formulation\, processing\, and scale-up considerations that influence product quality\, stability\, and patient experience\, while learning how Quality by Design (QbD) principles help de-risk development at every stage. Gain practical insights into topical formulation development\, scale-up challenges\, and strategies for successful\, reliable commercialization.
URL:https://thebiocalendar.com/event/from-concept-to-market-scaling-and-manufacturing-semi-solid-topical-drugs-free-webinar/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/02-23-26-MedPharm-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260219T110000
DTEND;TZID=America/Los_Angeles:20260219T120000
DTSTAMP:20260422T123746
CREATED:20260115T132237Z
LAST-MODIFIED:20260127T223118Z
UID:9784-1771498800-1771502400@thebiocalendar.com
SUMMARY:Building Smarter Cell Therapies with AI and Synthetic Biology
DESCRIPTION:Cell therapy development is entering a phase where complexity can no longer be managed by intuition alone. In this Cell & Gene Live\, Cell & Gene’s Chief Editor\, Erin Harris\, is joined by Timothy Lu\, M.D.\, Ph.D\, Co-Founder and CEO of Senti Biosciences and Claire Aldridge\, Ph.D.\, Board of Directors/Scientific Advisor\, to explore how AI and synthetic biology are being applied to engineer more precise\, controllable\, and scalable cell therapies. The conversation will examine the real advantages and limitations of using AI in complex CGT modalities. They will highlight the technologies that are generating the most excitement today and discuss how these approaches are beginning to shift development\, manufacturing\, and clinical strategy.
URL:https://thebiocalendar.com/event/building-smarter-cell-therapies-with-ai-and-synthetic-biology/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/26_02-CGL-LinkedIn-1280x720-OD.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260218T160000
DTEND;TZID=America/Los_Angeles:20260218T183000
DTSTAMP:20260422T123746
CREATED:20260127T155653Z
LAST-MODIFIED:20260127T155653Z
UID:9820-1771430400-1771439400@thebiocalendar.com
SUMMARY:BVS and BioMed Realty's Biotech Community Event in SSF
DESCRIPTION:Join Us for the BVS and BioMed Realty Biotech Community Event! \nMark your calendars for a great opportunity to connect with industry leaders\, explore innovative products\, and mingle with fellow professionals in the biotech community. \nThe vendor fair is held at The Forum\, in the same building as Amgen and next to Genentech\, right in the heart of the large pharma/biotechs in South San Francisco. \n✨ What to Expect: \n    Vendor Exhibit: Discover a diverse range of exhibitors showcasing cutting-edge technology and services in the biotech space.\n    Networking Opportunities: Engage with fellow industry experts\, forge new connections\, and exchange ideas that could shape the future of biotech.\n    Appetizers & Drinks: Enjoy delicious refreshments as you network and explore the vendor exhibits. \nWe welcome the entire Bay Area Biotech Community to join us for this exciting event! This is a wonderful chance for everyone to come together\, share insights\, and celebrate the vibrant biotech landscape in our region. \nAdmission Details:\nFREE for life science job-related employees (including researchers\, scientists\, purchasing\, clinical\, manufacturing\, non-sales/bus dev positions etc.) from life science companies and research institutes.\n$200 fee for product and service providers who sell to the life science community (e.g. BVS suppliers\, business development/sales\, marketing\, lawyers\, consultants)\, which includes access to the event but does not include an exhibitor table. Exhibitor tables can be purchased separately. \nFor exhibitor tables\, please visit our website and register at: https://bvsconnection.com/events \nPlease feel free to invite others in the community that could benefit from attending. \nWe look forward to seeing you there!
URL:https://thebiocalendar.com/event/bvs-and-biomed-realtys-biotech-community-event-in-ssf-6/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2026/01/Biotech-Event-Flyer-02-18-26-2250x4000px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260218T130000
DTEND;TZID=America/Los_Angeles:20260218T140000
DTSTAMP:20260422T123746
CREATED:20260211T190213Z
LAST-MODIFIED:20260211T190213Z
UID:9891-1771419600-1771423200@thebiocalendar.com
SUMMARY:AI In Clinical Trials: What's New & What's Hype?
DESCRIPTION:Back By Popular Demand!\nOur third Clinical Leader Live on AI will go beyond the buzzwords to focus on what’s actually working in clinical operations.  \nYou will hear about some of the newest real-world applications\, lessons learned from early adopters\, and how to spot hype before it costs you time or money.  \nRegistration is free with thanks to our sponsors for this live event: Medable\, PPD Clinical Research Business of Thermo Fisher Scientific and AG Mednet.
URL:https://thebiocalendar.com/event/ai-in-clinical-trials-whats-new-whats-hype/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/26_02_CLL_468x60.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260218T110000
DTEND;TZID=America/Los_Angeles:20260218T120000
DTSTAMP:20260422T123746
CREATED:20260107T182155Z
LAST-MODIFIED:20260107T182155Z
UID:9748-1771412400-1771416000@thebiocalendar.com
SUMMARY:Four Common Pitfalls to Avoid in UF/DF Setup and Scale-Up
DESCRIPTION:Ultrafiltration/Diafiltration (UF/DF) processes that look robust at the development scale often expose critical weaknesses during scale-up or tech transfer—resulting in capacity constraints\, excessive manual intervention\, delayed timelines\, or manufacturing risk. In many cases\, these issues trace back to early UF/DF decisions that seemed reasonable at the time but didn’t fully account for scalability\, system design\, or cross-functional alignment. \nIn this webinar\, we’ll break down four of the most common—and costly—pitfalls in UF/DF setup and scale-up\, including poor filter sizing and membrane selection\, overreliance on manual operations\, system design limitations\, and breakdowns in communication between Process Development and MSAT teams. Through practical examples drawn from downstream workflows\, we’ll show how these pitfalls emerge\, why they persist\, and how they impact process robustness and manufacturing success. \nAttendees will leave with practical strategies to design more scalable UF/DF processes\, reduce manual burden\, improve system selection\, and strengthen PD–MSAT collaboration—helping teams avoid late-stage surprises and enabling smoother tech transfer to manufacturing. \n   ~ Avoid scale-up surprises with membrane selection strategies that are fit-for-purpose\n    ~Reduce manual burden and operational risk by understanding when automation and system design choices matter most for robust\, scalable UF/DF operations\n    ~Enable smoother tech transfer by improving alignment and communication between Process Development and MSAT teams early in process design
URL:https://thebiocalendar.com/event/four-common-pitfalls-to-avoid-in-uf-df-setup-and-scale-up/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/02-18-26-Repligen-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260218T080000
DTEND;TZID=America/Los_Angeles:20260218T170000
DTSTAMP:20260422T123746
CREATED:20260218T162115Z
LAST-MODIFIED:20260218T162115Z
UID:9918-1771401600-1771434000@thebiocalendar.com
SUMMARY:How AI-Enabled Digital Validation Technologies Enable the Predictive Plant
DESCRIPTION:As life sciences manufacturers progress along their digital maturity journey\, validation data is increasingly recognized as a strategic asset rather than a compliance artifact. In this session\, experts will illustrate how digitally mature organizations leverage Digital Validation Technologies (DVTs) as a core component of their broader digital ecosystem. Attendees will gain a clear understanding of how AI-enabled digital validation accelerates the move from compliance-driven validation to predictive asset intelligence—supporting scalable manufacturing\, resilient operations\, and sustained readiness for future regulatory and business demands. \nSecond-generation\, AI-enabled Digital Validation Technologies (DVTs)
URL:https://thebiocalendar.com/event/how-ai-enabled-digital-validation-technologies-enable-the-predictive-plant/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/03-18-26-CAI-LinkedIn-1280x720-v1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260218
DTEND;VALUE=DATE:20260220
DTSTAMP:20260422T123746
CREATED:20260116T120621Z
LAST-MODIFIED:20260116T120621Z
UID:9792-1771372800-1771545599@thebiocalendar.com
SUMMARY:SapioCon 2026
DESCRIPTION:2026 marks a turning point in life sciences — the year AI moves from concept to core capability. With ELaiN\, the world’s first AI-native ELN\, Sapio is leading this transformation\, making software simple to use and empowering labs to think faster and innovate smarter. \nThis is your chance to connect with industry leaders\, network with peers\, and talk with Sapio experts. \nBe there to experience firsthand how AI is redefining biopharma R&D and diagnostics\, connect with peers at the forefront of change\, and see what’s next in the journey toward smarter science. \nBoston is the stage. ELaiN is the catalyst. You are the future. By the end of SapioCon\, you’ll walk away with: \n\nA clearer vision for applying AI and automation in science\nPractical strategies from real customer experiences\nNew technical skills and product knowledge\nConnections that expand your professional network and impact\n\n\n\nWhat to Expect at SapioCon 2026: \n\nCustomer Stories: Real Results\, Real Impact\nLearn how peers overcame challenges similar to yours\nAI Keynotes: The Future of Science\, Now!\nUnderstand how AI can free researchers from repetitive tasks\, accelerate discovery\, and amplify human insight — with practical examples you can bring back to your lab\nExciting Product Reveals\nGet to know what’s new and what’s coming soon.\nSolution Presentations: Explore What’s Possible\nLearn how to streamline scientific data\, automate workflows\, and increase productivity across your organization\nTech Talks: Behind the Innovation\nGiving you actionable tools for implementation\nShort Courses: Hands-On Learning\nBuild your practical skills\nand much more …
URL:https://thebiocalendar.com/event/sapiocon-2026/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260217T110000
DTEND;TZID=America/Los_Angeles:20260217T130000
DTSTAMP:20260422T123746
CREATED:20260121T135208Z
LAST-MODIFIED:20260121T135349Z
UID:9802-1771326000-1771333200@thebiocalendar.com
SUMMARY:Outsourced Pharma Capabilities Update: AI Drug Development (Free Virtual Event)
DESCRIPTION:In this Capabilities Update\, industry leaders will share where AI is delivering value today—from hit-to-lead optimization and analytical method development to model-informed process development and digital CPV/QMS—and how CDMOs and sponsors can collaborate to reduce cycle times\, improve quality\, and de-risk scale-up.  \nAttendees will gain a practical CDMO readiness checklist and insights into sponsor expectations for the next 12 months\, along with real-world guidance on integrating AI into route scouting\, tech transfer\, scale-up\, batch release\, and quality decision-making.
URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-ai-drug-development-free-virtual-event/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/Biocal.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260217T080000
DTEND;TZID=America/Los_Angeles:20260217T113000
DTSTAMP:20260422T123746
CREATED:20251125T141905Z
LAST-MODIFIED:20251125T141905Z
UID:9576-1771315200-1771327800@thebiocalendar.com
SUMMARY:Houston Life Sciences Commercial Real Estate Conference
DESCRIPTION:Join us at the Houston Life Sciences Commercial Real Estate Conference\, where researchers\, developers\, investors\, and real estate professionals converge to examine the forces shaping one of the fastest-growing innovation hubs in the country. Houston’s world-class medical institutions\, biotech startups\, and research facilities are driving breakthroughs in healthcare\, pharmaceuticals\, and medical technology.  \nThis event will highlight how real estate development\, capital investment\, and cross-sector collaboration are fueling the growth of the city’s life sciences ecosystem. From building next-generation lab and manufacturing facilities to fostering partnerships between academia and industry\, attendees will gain valuable insights into the future of life sciences and its impact on commercial real estate.
URL:https://thebiocalendar.com/event/houston-life-sciences-commercial-real-estate-conference/
LOCATION:Houston\, Houston\, TX\, 77001\, United States
CATEGORIES:Forum
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260212T110000
DTEND;TZID=America/Los_Angeles:20260212T120000
DTSTAMP:20260422T123746
CREATED:20260211T180019Z
LAST-MODIFIED:20260211T180019Z
UID:9879-1770894000-1770897600@thebiocalendar.com
SUMMARY:Outsourced Pharma Capabilities Update - Cell & Gene
DESCRIPTION:Watch leading CDMOs share their current capabilities\, facility locations\, and timelines—helping you identify the right partners for your cell and gene development and manufacturing needs. \nExplore the fast-growing field of cell and gene therapy\, including:\n– Cell sourcing and expansion\n– Vector design and gene therapy delivery mechanisms\n– Formulation development and GMP-compliant processes ensuring patient safety and product quality \nWhat to expect:\n– Short digital presentations with live interaction providing an inside look at supplier capacity\n– Opportunity to ask questions and assess whether each CDMO can meet your needs\n– All accessible from your computer—no travel required \nPlease note: This event is designed for biopharma companies seeking CDMO partners with available capacity.
URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-cell-gene/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/Biocal-6.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260211T130000
DTEND;TZID=America/Los_Angeles:20260211T140000
DTSTAMP:20260422T123746
CREATED:20260211T175645Z
LAST-MODIFIED:20260211T175645Z
UID:9875-1770814800-1770818400@thebiocalendar.com
SUMMARY:Outsourced Pharma Capabilities Update - Small Molecule Drug Product (Free Virtual Event)
DESCRIPTION:Watch leading CDMOs share their current capabilities\, facility locations\, and timelines—helping you identify the right partners for your small molecule drug product development and manufacturing needs. \nWhat to expect:\n– Short digital presentations providing an inside look at supplier capacity\n– Live Q&A to ask questions and assess whether each CDMO can meet your needs\n– Convenient access from your computer—no travel required \nPlease note: This event is designed for biopharma companies seeking CDMO partners with capabilities that match their needs.
URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-small-molecule-drug-product-free-virtual-event/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/Biocal-4.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260211T110000
DTEND;TZID=America/Los_Angeles:20260211T120000
DTSTAMP:20260422T123746
CREATED:20260109T181835Z
LAST-MODIFIED:20260109T181835Z
UID:9767-1770807600-1770811200@thebiocalendar.com
SUMMARY:Optimizing Process Development Through Upstream And Downstream Integration
DESCRIPTION:Join Bioprocess Online Chief Editor Tyler Menichiello on February 11\, at 11 a.m. Eastern\, for an interactive panel discussion exploring how upstream and downstream development teams can work together to reduce risk\, accelerate process scaling\, and support smoother downstream tech transfer.  \nThe panel will feature Eric Doerr\, drug substance technical lead at Sanofi; Mark Fitchmun\, president and CEO of Somatek; Doug MacDonald\, the director of purification and process development at Immunome; Branden Salinas\, Ph.D.\, VP of process sciences at Umoja Biopharma; and Raj Prabu Vijayakumar Saraswathi\, Director of Biologics Process Development at RAPT Therapeutics. These leaders\, with collective experience across key modality types (e.g.\, mAbs\, ADCs\, and CGTs)\, will share their wisdom on the importance of coordination between upstream and downstream teams to avoid bottlenecks and mitigate failure.
URL:https://thebiocalendar.com/event/optimizing-process-development-through-upstream-and-downstream-integration/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/26_02-BPOL-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260210T130000
DTEND;TZID=America/Los_Angeles:20260210T140000
DTSTAMP:20260422T123746
CREATED:20260115T190903Z
LAST-MODIFIED:20260115T190903Z
UID:9788-1770728400-1770732000@thebiocalendar.com
SUMMARY:Bridging Discovery and CMC with Rapid Pools
DESCRIPTION:The rapid growth of complex antibody modalities—including bispecifics\, multispecifics\, Fc-fusions\, and emerging formats—has widened the gap between discovery-stage expression systems and manufacturability. Transient expression\, still widely used for screening and optimization\, often fails to reveal architecture-driven liabilities such as chain imbalance\, mispairing\, instability\, aggregation\, or poor effective yield. As a result\, promising molecular formats may be prematurely deprioritized based on incomplete expression data\, or advanced with hidden risks that surface only during cell line development and CMC. \nAsimov’s Rapid Pools platform addresses this challenge by enabling high-throughput generation of stable CHO expression pools using a new high-efficiency transposase\, CHO-K1 GS host\, and model-guided vector design. By providing early\, CLD-relevant expression and assembly data\, RapidPools allow protein engineers to directly evaluate the manufacturability of complex architectures during the design phase. This enables informed sequence\, vector\, and chain-balancing optimizations that can derisk differentiated formats that might otherwise be dropped\, while more accurately identifying designs unlikely to scale. \nAttendees will learn how integrating stable expression readouts into protein engineering workflows improves predictability\, reduces late-stage risk\, and expands the viable design space for next-generation antibody therapeutics.
URL:https://thebiocalendar.com/event/bridging-discovery-and-cmc-with-rapid-pools/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/Untitled-design-48.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260210T110000
DTEND;TZID=America/Los_Angeles:20260210T120000
DTSTAMP:20260422T123746
CREATED:20260113T134847Z
LAST-MODIFIED:20260113T134847Z
UID:9780-1770721200-1770724800@thebiocalendar.com
SUMMARY:Charting the Path to First-In-Human: Strategic Readiness for Early Clinical Success
DESCRIPTION:The road to first-in-human is one of the most pivotal—and complex—stages in drug development. It’s a journey that requires foresight\, coordination\, and a clear map connecting scientific innovation to operational execution. \nIn this live webinar\, experts from inSeption Group will outline proven strategies for navigating each phase of early clinical readiness and IND preparation. Learn how to anticipate challenges\, align cross-functional teams\, and build the operational “trail map” that ensures your program reaches its first patient efficiently and compliantly.
URL:https://thebiocalendar.com/event/charting-the-path-to-first-in-human-strategic-readiness-for-early-clinical-success/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/02-10-26-ISG-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260210
DTEND;VALUE=DATE:20260213
DTSTAMP:20260422T123746
CREATED:20251212T172425Z
LAST-MODIFIED:20260106T173034Z
UID:9645-1770681600-1770940799@thebiocalendar.com
SUMMARY:IO360° Summit
DESCRIPTION:IO360° Delivers 4 Key Benefits\n  \n\n\n\n\n1.Delivering a 360° IO Community​ to Network and Form Collaborations\nBuild faster and more impactful collaborations with researchers\, clinicians\, biopharma leaders\, investors and policymakers to advance cancer treatments \n2. The Latest Data Driving Broader Impact\nHear directly from KOLs on the latest data to help advance and improve outcomes for more patients across a wider range of cancers\n​​​​​\n3. 360° Future-Focused Agenda\nStay ahead of the curve through 100+ multi-dimensional talks covering preclinical research\, translational science\, clinical development\, operational strategies\, cell therapy and business advancements \n4. 10+ Hours of Networking Opportunities\nMeet with key stakeholders in biopharma\, academia\, investors and regulatory through 1:1 meetings and scheduled functions \n\n15% Discount with Code BIG4BIO15
URL:https://thebiocalendar.com/event/io360-summit-2/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260209
DTEND;VALUE=DATE:20260213
DTSTAMP:20260422T123746
CREATED:20260106T192251Z
LAST-MODIFIED:20260106T192251Z
UID:9719-1770595200-1770940799@thebiocalendar.com
SUMMARY:Advanced Therapies Week
DESCRIPTION:Now in its 21st year\, Advanced Therapies Week is the premier biotech partnering event in the United States. Bringing together leaders in research\, therapeutic development\, and advanced manufacturing. \nJoin us at the Convention Center San Diego\, 09–12 February 2026 and get connected with the cell and gene therapy ecosystem.
URL:https://thebiocalendar.com/event/advanced-therapies-week-2/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:Partnering
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260207
DTEND;VALUE=DATE:20260213
DTSTAMP:20260422T123746
CREATED:20251125T141612Z
LAST-MODIFIED:20251125T141612Z
UID:9575-1770422400-1770940799@thebiocalendar.com
SUMMARY:SLAS2026 International Conference & Exhibition
DESCRIPTION:The SLAS International Conference and Exhibition is the flagship annual conference and exhibition presented by SLAS and the must-attend event dedicated to life sciences discovery and laboratory automation technology.  \nSchedule\nFebruary 7-8: Pre-conference Short Courses and Technology Provider Showcase\nFebruary 9-11: Dynamic Exhibition and Eight Scientific Tracks\nFebruary 12: NEW! Thrive in Science: SLAS Women’s Leadership Forum \nAttendance in 2025: 7500+ life sciences researchers and laboratory automation technology professionals under one roof! \nFeatures\nExhibition: SLAS2026 delivers a fast-paced exhibition experience\, including opportunities for business-to-business and business-to-consumer interactions. Attendees will see the latest products and services\, supplies and suppliers\, and have time to investigate automation solutions to drive new discoveries! \nEducation: Learn from experts across a broad spectrum of academia and industry\, sharing their life sciences research and the technological advances that enhance their success. Exhibitor tutorials and case studies\, NexusXp: The Connected Lab returns with panel discussions highlighting the DMTA cycle\, SLAS Topical Interest Group discussions and more. \nNetworking: Join discussions and interact with attendees at networking\, special interest and social events. \nRecognition: SLAS Travel Awards make it possible for podium and poster presenters to earn a free trip to SLAS2026. The SLAS Innovation Award honors the most innovative podium presentation and Student Poster Awards provide new scientists with the opportunity to present their research\, receive feedback and possibly win a $500 prize!
URL:https://thebiocalendar.com/event/slas2026-international-conference-exhibition/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Expo,Networking,Symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260205T110000
DTEND;TZID=America/Los_Angeles:20260205T120000
DTSTAMP:20260422T123746
CREATED:20260109T183224Z
LAST-MODIFIED:20260109T183224Z
UID:9771-1770289200-1770292800@thebiocalendar.com
SUMMARY:Selecting a Prefillable Syringe System with Confidence (Free Virtual Discussion)
DESCRIPTION:Join West Pharmaceutical Services for a discussion on how to simplify the complex process of selecting a prefillable syringe system. With combination product requirements and ambiguous regulations\, traditional evaluation and testing can slow development and delay clinical timelines. \nThis presentation introduces the West Synchrony™ S1 Prefillable Syringe System—a fully integrated\, verified solution combining the barrel\, plunger\, and needle shield/tip cap from a single supplier. Discover how this harmonized system helps emerging biotech teams reduce risk\, save time and resources\, and accelerate the path to clinical fill. \nWhat you’ll learn:\n* What the West Synchrony™ S1 system is\n* How it streamlines development and supports faster submissions\n* How it reduces cost\, complexity\, and supply chain risk
URL:https://thebiocalendar.com/event/selecting-a-prefillable-syringe-system-with-confidence-free-virtual-discussion/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/02-05-26-West-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260205T110000
DTEND;TZID=America/Los_Angeles:20260205T120000
DTSTAMP:20260422T123746
CREATED:20260107T153707Z
LAST-MODIFIED:20260107T154206Z
UID:9744-1770289200-1770292800@thebiocalendar.com
SUMMARY:The Unfiltered Truth About CDMO Selection (Free Virtual Event)
DESCRIPTION:Watch industry experts share practical guidance on how to evaluate CDMOs beyond the basics—focusing on experience\, talent\, and technologies that align with your development goals. \nSpeakers:\nJana Spes\, CEO & Co-founder\, JT Biopharma Partners\nPeter Bigelow\, CEO & Co-founder\, SCmple Solutions\nChristine Sheaffer\, Manufacturing & Supply Consultant\, Executive Leader Biotech Industry\nJeff Buguliskis\, PhD\, Chief Editor\, Outsourced Pharma \nCan’t watch the live discussion on February 5th? No problem! All registrants will receive an on-demand recording after the event.
URL:https://thebiocalendar.com/event/the-unfiltered-truth-about-cdmo-selection-free-virtual-event/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/26_02-OPL-HTML-600x300-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260204T110000
DTEND;TZID=America/Los_Angeles:20260204T120000
DTSTAMP:20260422T123746
CREATED:20260109T153939Z
LAST-MODIFIED:20260109T153939Z
UID:9757-1770202800-1770206400@thebiocalendar.com
SUMMARY:Designing Drug Substance Processes for Fill-Finish Compatibility (Free Virtual Event)
DESCRIPTION:Join KBI Biopharma and Argonaut Manufacturing Services for a candid fireside chat on breaking down silos between drug substance and drug product. Explore how an integrated\, quality-aligned approach can simplify execution and reduce timelines by 2–3 months from cell line development to drug product manufacturing. \nWhat you’ll learn:\n* How to overcome common CDMO and fill-finish integration challenges\n* Ways to reduce bottlenecks and avoid late-stage delays\n* Practical strategies to align quality\, regulatory\, and manufacturing processes end to end
URL:https://thebiocalendar.com/event/designing-drug-substance-processes-for-fill-finish-compatibility-free-virtual-event/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/02-04-26-KBI-eblast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260204T110000
DTEND;TZID=America/Los_Angeles:20260204T120000
DTSTAMP:20260422T123746
CREATED:20260107T153015Z
LAST-MODIFIED:20260107T154103Z
UID:9738-1770202800-1770206400@thebiocalendar.com
SUMMARY:Injected\, Infused\, or Implanted: A Penetrating Look At Patient Centricity (Free Virtual Event)
DESCRIPTION:Join Drug Delivery Leader’s Chief Editor Tom von Gunden as he engages drug delivery experts Beate Bittner\, Shannon Hoste\, Jonathan Amaya-Hodges\, and Fran DeGrazio in a discussion of innovations and advances in injectable\, infusible\, and implantable devices\, systems\, platforms\, and combinations.  \nFocusing on unmet patient needs and expanded therapeutic targets\, the panel will discuss approaches and technologies that:\n–   enable delivery outside of clinical settings\, including via at-home\, patient self-administration\n–    expand the range of options for delivering complex biologics and other advanced therapies\n–    leverage combination products or combined use systems for patient convenience and treatment efficacy\n–    lessen the overall frequency and burden of treatment regimens \nCan’t watch the live discussion on February 4th? No problem! All registrants will receive an on-demand recording after the event.
URL:https://thebiocalendar.com/event/injected-infused-or-implanted-a-penetrating-look-at-patient-centricity-free-virtual-event/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/26_02-DDL-HTML-600x300-1.png
END:VEVENT
END:VCALENDAR